A 2025 pooled analysis showed meaningful weight loss across all menopause stages: Pre-menopausal women: 18.2% average weight loss Peri-menopausal women: 15.0% average weight loss Post-menopausal women: 15.7% average weight loss The hormonal changes of perimenopause declining estrogen, increasing insulin resistance, redistribution of fat toward the abdomen are often precisely what makes weight management feel impossible during midlife
Additionally, their larger size and chemical properties make it difficult for them to be absorbed through the intestinal wall into the bloodstream
Increased competition from these new products, even if they are brand-name, could help put downward pressure on prices over time
Show more 4.7 Based on 3 ratings 2 1 0 0 0 Write a Review What customers say (3) Rating Rating (2) (1) (0) (0) (0) Languages English Languages English (2) Show auto-translated reviews (1) Show auto-translated reviews (1) Show reviews with images only Review images Show reviews with images only English Translated reviews iHerb customer Posted on Jun 1, 2026 United States 97 0 0 2 Verified purchase One of the better ones out there
However, the primary difference lies in receptor activity: * Semaglutide: Primarily targets GLP-1 * Tirzepatide: Dual agonist targeting GLP-1 and GIP * Retatrutide: Triple agonist targeting GLP-1, GIP, and glucagon This expanded mechanism may offer researchers broader opportunities to study integrated metabolic pathways
This isnt the first time Clarkson has addressed her fluctuating weight over the years, however